Cytotoxicity of lymphokine-activated killer cells in conjunction with pingyangmycin to human tongue carcinoma (Tca8113) in vitro and vivo
Duan, J.G.
Zhonghua Kou Qiang Yi Xue Za Zhi 28(4): 231-233
1993
ISSN/ISBN: 1002-0098 PMID: 7513629 Document Number: 414060
Document emailed within 1 workday
Related Documents
Wang, Z.P.; Zheng, R.L.; Chen, Y.R.; Liu, G.D. 1997: Tretinoin or retinol enhancement of lymphokine-activated killer cell proliferation and cytotoxicity against human bladder cancer cells in vitro Zhongguo Yao Li Xue Bao 18(6): 522-524Liu, G.R. 1993: Cytotoxicity of human lymphokine-activated killer cells against mitotic phase tumor cells Zhonghua Yi Xue Za Zhi 73(9): 547-548; 576
Segerson, E.C.; Gunsett, F.C. 1994: In vitro and in vivo effects of lymphokine-activated killer cells upon preattachment ovine conceptuses Journal of Immunology 152(6): 2938-2951
Kaufmann, Y.; Levanon, M.; Davidsohn, J.; Ramot, B. 1987: Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity Journal of Immunology 139(3): 977-982
Lamers, H.J.; Gratama, J.W.; van Putten, W.L.; Stoter, G.; Bolhuis, R.L. 1991: Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes Cancer Research 51(9): 2324-2328
Nio, Y.; Zighelboim, J.; Berek, J.S.; Bonavida, B. 1990: Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers Anticancer Research 10(2a): 441-446
Chen, M.F.; Suzuki, H.; Yano, S. 1992: Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells Anticancer Research 12(2): 451-456
Merluzzi, V.J.; Trail, P.A.; Last-Barney, K. 1986: Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow Journal of Immunology 137(8): 2425-2427
Montagna, D.; Maccario, R.; Ugazio, A.G.; Mingrat, G.; Burgio, G.R. 1988: Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity Clinical and Experimental Immunology 71(1): 177-181
Iwasaki, K.; Kikuchi, H.; Miyatake, S.; Aoki, T.; Yamasaki, T.; Oda, Y. 1990: Infiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model Cancer Research 50(8): 2429-2436
McMannis, J.D.; Fisher, R.I.; Creekmore, S.P.; Braun, D.P.; Harris, J.E.; Ellis, T.M. 1988: In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2 Journal of Immunology 140(4): 1335-1340
Marincola, F.M.; Da Pozzo, L.F.; Drucker, B.J.; Holder, W.D. 1990: Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model Surgery 108(5): 919-929
Galili, U.; Rosenthal, L.; Galili, N.; Klein, E. 1979: Activated T cells in the synovial fluid of arthritic patients: characterization and comparison with in vitro activated human and murine T cells in cooperation with monocytes in cytotoxicity Journal of Immunology 122(3): 878-883
Lauria, F.; Raspadori, D.; Rondelli, D.; Ventura, M.A.; Foà, R. 1994: In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival Leukemia 8(5): 724-728
Sznol, M.; Clark, J.W.; Smith, J.W.; Steis, R.G.; Urba, W.J.; Rubinstein, L.V.; VanderMolen, L.A.; Janik, J.; Sharfman, W.H.; Fenton, R.G. 1992: Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma Journal of the National Cancer Institute 84(12): 929-937
Nakano, E. 1992: Lymphokine-activated killer (LAK) therapy for metastatic renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1305-1309
Lynch, D.H.; Miller, R.E. 1990: Induction of murine lymphokine-activated killer cells by recombinant IL-7 Journal of Immunology 145(6): 1983-1990
Glassman, A.B. 1989: Interleukin-2 and lymphokine activated killer cells: promises and cautions Annals of Clinical and Laboratory Science 19(1): 51-55
Hamada, F.; Fuchimoto, S.; Orita, K. 1989: Suppression of lymphokine activated killer (LAK) cells by immunosuppressive substance Research Communications in Chemical Pathology and Pharmacology 65(1): 81-95
Ballas, Z.K.; Rasmussen, W. 1987: Lymphokine-activated killer (LAK) cells. III. Characterization of LAK precursors and susceptible target cells within the murine thymus Journal of Immunology 139(10): 3542-3549